First AD

Second AD

OncLive Peer Exchange® 

® Peer Exchange video program comprises lively expert panel discussions feature peer-to-peer exchanges providing authoritative insights, opinions, and perspectives on important issues facing today’s health care professionals. Episodes focus on updates and insights across solid and hematologic malignancies, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecological cancers, and hematologic malignancies. 

Acute Lymphoblastic Leukemia: The Current and Future State of Care

Peer Exchange

Four clinicians share best practices for assessing minimal residual disease (MRD) for ALL, touching on how these practices are evolving over time. 

Assessing Minimal Residual Disease in Patients with Acute Lymphoblastic Leukemia

Patient Presentation and Diagnosis in Acute Lymphoblastic Leukemia 

Differentiating Subtypes of Acute Lymphoblastic Leukemia

Emergent Data Concerning Risk Factors for Acute Lymphoblastic Leukemia

Standard Prognoses for Pediatric and Adult Patients with Acute Lymphoblastic Leukemia

Treatment Options for Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia in the Frontline Setting

The Evolving Treatment Paradigm for Patients with Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Recently Presented Data Informing the Treatment of Patients with Philadelphia Chromosome-negative Acute Lymphoblastic Leukemia

Considerations for the Treatment of Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

CAR T-cell Therapy in Patients with R/R Acute Lymphoblastic Leukemia

Inotuzumab as an Option for Patients with R/R Acute Lymphoblastic Leukemia

Applications for Blinatumomab in Treating Patients with R/R Acute Lymphoblastic Leukemia

Emerging Data Supporting the use of Tisagenlecleucel in Patients with R/R Acute Lymphoblastic Leukemia 

On the Horizon: Exciting Prospects in the Acute Lymphoblastic Leukemia Treatment Landscape